CONTINGENCIES, INDEMNITIES AND COMMITMENTS (Narrative) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Total commitments	$ 595,164
Gronich Securities Class Action [Member]
Loss Contingency, Lawsuit Filing Date	November 16, 2017
Loss Contingency, Name of Defendant	Omega Healthcare Investors, Inc., C. Taylor Pickett, Robert O. Stephenson, and Daniel J. Booth
Loss Contingency, Name of Plaintiff	Dror Gronich
Loss Contingency, Domicile of Litigation	United States District Court for the Southern District of New York (the "Court")
Steve Klein Class Action [Member]
Loss Contingency, Lawsuit Filing Date	November 17, 2017
Loss Contingency, Name of Defendant	Omega Healthcare Investors, Inc., C. Taylor Pickett, Robert O. Stephenson, and Daniel J. Booth
Loss Contingency, Name of Plaintiff	Steve Klein
Loss Contingency, Domicile of Litigation	United States District Court for the Southern District of New York
Consolidated Amended Class Action Complaint [Member]
Loss Contingency, Lawsuit Filing Date	May 25, 2018
Loss Contingency, Name of Plaintiff	Setzer and additional plaintiff Earl Holtzman
Loss Contingency, Allegations	alleges that the defendants violated the Securities Exchange Act of 1934, as amended (the "Exchange Act"), by making materially false and/or misleading statements, and by failing to disclose material adverse facts about the Company's business, operations, and prospects, including the financial and operating results of one of the Company's operators, the ability of such operator to make timely rent payments, and the impairment of certain of the Company's leases and the uncollectibility of certain receivables. The Securities Class Action, which purports to assert claims for violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, as well as Section 20(a) of the Exchange Act, seeks an unspecified amount of monetary damages, interest, fees and expenses of attorneys and experts, and other relief.
Loss Contingency, Laws Affected	purports to assert claims for violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, as well as Section 20(a) of the Exchange Act, seeks an unspecified amount of monetary damages, interest, fees and expenses of attorneys and experts, and other relief. The Company and the officers named in the Securities Class Action filed a Motion to Dismiss on July 17, 2018 and the Court heard Oral Argument on February 13, 2019.
Stour Bridge Investments Limited Liability Company Lawsuit [Member]
Loss Contingency, Lawsuit Filing Date	August 22, 2018
Loss Contingency, Name of Defendant	Callen et al
Loss Contingency, Name of Plaintiff	Stourbridge Investments LLC
Loss Contingency, Allegations	The complaint alleges, among other things, that the defendants are responsible for the Company's failure to disclose the financial condition of Orianna Health Systems, the alleged non-disclosures that are also the subject of the Securities Class Action described above.
Brekka Lawsuit [Member]
Loss Contingency, Lawsuit Filing Date	February 21, 2019
Loss Contingency, Name of Defendant	MedEquities Realty Trust, Inc.
Loss Contingency, Name of Plaintiff	Brekka
Loss Contingency, Domicile of Litigation	United States District Court for the District of Maryland
Loss Contingency, Allegations	The complaint alleges, among other things, that MedEquities, members of the MedEquities' Board, and the Company violated Section 14(a) of the Securities Exchange Act by making materially incomplete and misleading statements in, and/or omitting certain information that is material to stockholders from, the Registration Statement on Form S-4, as filed with the SEC on February 11, 2019 (the "Form S-4"), relating to the merger.
Loss Contingency, Laws Affected	violated Section 14(a) of the Securities Exchange Act
Scarantino [Member]
Loss Contingency, Name of Defendant	McRoberts
Loss Contingency, Name of Plaintiff	Scarantino
Loss Contingency, Domicile of Litigation	Circuit Court for Baltimore City, Maryland
Loss Contingency, Allegations	breaches of fiduciary duties by the MedEquities' board of directors in connection with its approval of the merger and the omission from the Form S-4 of certain information that is material to stockholders
Bushansky Lawsuit [Member]
Loss Contingency, Lawsuit Filing Date	March 17, 2019
Loss Contingency, Name of Defendant	MedEquities Realty Trust, Inc.
Loss Contingency, Name of Plaintiff	Bushansky
Loss Contingency, Domicile of Litigation	United States District Court for the Middle District of Tennessee
Loss Contingency, Allegations	that MedEquities and its directors violated Section 14(a) of the Securities Exchange Act by making materially incomplete and misleading statements in, and/or omitting certain information that is material to stockholders from, the Combined Proxy Statement and Form S-4, relating to the merger
Russell [Member]
Loss Contingency, Lawsuit Filing Date	March 29, 2019
Loss Contingency, Name of Defendant	MedEquities Realty Trust, Inc.
Loss Contingency, Name of Plaintiff	Russell
Loss Contingency, Domicile of Litigation	Circuit Court of Maryland, Baltimore City, Maryland
Loss Contingency, Allegations	alleging, among other things, that MedEquities and members of the MedEquities board of directors breached their fiduciary duties by: (i) failing to fulfill their fiduciary oversight function; (ii) authorizing the filing of a materially incomplete and misleading proxy statement/prospectus; and (iii) authorizing in the company's Amended and Restated Bylaws the enactment of an exclusive venue designation whereby the Circuit Court for Baltimore City, Maryland is the sole and exclusive forum for certain litigation against the company, or if that court does not have jurisdiction, the U.S. District Court for the District of Maryland, Baltimore Division  (the "Exclusive Venue Bylaw"). Russell v. MedEquities Realty Trust, Inc., et al., Case No. C-03-CV-19-000721.
Indemnification Agreement [Member]
Total commitments	$ 16,700
Other Commitments, Description	In connection with certain facility transitions, we provided certain operators with indemnities. As of March 31, 2019, our maximum funding commitment under these indemnities approximates $16.7 million. Claims against these indemnities must occur within 18 months to 72 months of the transition date. These indemnities were provided to these operators upon transition and would be utilized in the event that the prior operators do not perform under their transition agreements. The Company does not expect to fund a material amount under these indemnity agreements.